HUP0002062A3 - Method for diagnosing bone dysbolism - Google Patents

Method for diagnosing bone dysbolism

Info

Publication number
HUP0002062A3
HUP0002062A3 HU0002062A HUP0002062A HUP0002062A3 HU P0002062 A3 HUP0002062 A3 HU P0002062A3 HU 0002062 A HU0002062 A HU 0002062A HU P0002062 A HUP0002062 A HU P0002062A HU P0002062 A3 HUP0002062 A3 HU P0002062A3
Authority
HU
Hungary
Prior art keywords
diagnosing bone
bone dysbolism
dysbolism
diagnosing
bone
Prior art date
Application number
HU0002062A
Other languages
English (en)
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of HUP0002062A2 publication Critical patent/HUP0002062A2/hu
Publication of HUP0002062A3 publication Critical patent/HUP0002062A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/108—Osteoporosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma
HU0002062A 1997-09-24 1998-07-31 Method for diagnosing bone dysbolism HUP0002062A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27647597 1997-09-24
PCT/JP1998/003421 WO1999015691A1 (fr) 1997-09-24 1998-07-31 Procede permettant de diagnostiquer un dysfonctionnement du metabolisme osseux

Publications (2)

Publication Number Publication Date
HUP0002062A2 HUP0002062A2 (hu) 2000-10-28
HUP0002062A3 true HUP0002062A3 (en) 2002-09-30

Family

ID=17569976

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002062A HUP0002062A3 (en) 1997-09-24 1998-07-31 Method for diagnosing bone dysbolism

Country Status (16)

Country Link
US (2) US6693175B2 (hu)
EP (1) EP0974671B1 (hu)
JP (1) JP4268684B2 (hu)
KR (1) KR100547395B1 (hu)
CN (1) CN1183159C (hu)
AT (1) ATE328281T1 (hu)
AU (1) AU739304B2 (hu)
CA (1) CA2269114A1 (hu)
DE (1) DE69834719D1 (hu)
HU (1) HUP0002062A3 (hu)
IL (1) IL129535A (hu)
NO (1) NO992472L (hu)
NZ (1) NZ335759A (hu)
RU (1) RU2203497C2 (hu)
WO (1) WO1999015691A1 (hu)
ZA (1) ZA986974B (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
BR9914834A (pt) 1998-10-28 2001-08-14 Snow Brand Milk Products Co Ltd Agente de tratamento de patobolismo ósseo, e, método para intensificar a atividade de fator inibidor de osteoclastogênese
JP3709332B2 (ja) * 2000-09-14 2005-10-26 株式会社エーシーバイオテクノロジーズ 骨粗鬆症の診断および／または骨粗鬆症骨折リスクの予測の方法
WO2002062990A1 (fr) * 2001-02-07 2002-08-15 Sankyo Company, Limited Anticorps et utilisation de cet anticorps
WO2002079256A1 (fr) * 2001-03-26 2002-10-10 Sankyo Company, Limited Anticorps et son utilisation
EP1377610A2 (en) 2001-04-03 2004-01-07 Société des Produits Nestlé S.A. Osteoprotegerin in milk
EP1270015A3 (en) * 2001-06-29 2004-02-25 Sankyo Company Limited A complex comprising OCIF and Polysaccharide
EP1482978A1 (en) * 2002-03-01 2004-12-08 Sankyo Company, Limited Pharmaceutical composition comprising osteoclastogenesis inhibitory factor
US7279451B2 (en) 2002-10-25 2007-10-09 Honeywell International Inc. Compositions containing fluorine substituted olefins
WO2004040969A1 (ja) * 2002-11-07 2004-05-21 Kumamoto Technology & Industry Foundation Ｇａｎｐ導入トランスジェニック哺乳動物及びその利用
KR100545064B1 (ko) * 2003-05-26 2006-01-24 김현기 인간 원암단백질에 특이적인 항체를 포함하는 간경변증진단 키트
EP2024005A4 (en) * 2006-05-17 2013-01-30 Univ New York State Res Found BIOMECHANICAL METHOD FOR THE TREATMENT OF FATIBILITY AND DIABETES
US10029089B2 (en) 2010-10-15 2018-07-24 Research Foundation For The State University Of New York, The Compositions and methods for enhancing the biological response to chemical agents and physical stimuli
RU2524616C1 (ru) * 2013-01-21 2014-07-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Владивостокский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГОУ ВПО ВГМУ Минздрава России) Способ диагностики ранней стадии ревматоидного артрита
GB201302257D0 (en) 2013-02-08 2013-03-27 Nobel Biocare Services Ag Method for measuring bone loss rate
CN106405064B (zh) * 2016-08-30 2018-10-26 嘉兴行健生物科技有限公司 一种40岁以上女性骨转换率的评估方法
CN109540818A (zh) * 2018-12-21 2019-03-29 云南农业大学 一种基于钙、磷血液生化标记选育武定鸡的方法
CN113621060B (zh) * 2020-05-07 2023-07-04 浙江瑞硕生物技术有限公司 一种opg抗体对及其应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
WO1990004417A1 (en) * 1988-10-24 1990-05-03 Bruce Caterson Methods of and compositions for diagnosing, monitoring and treating the early stages of osteoarthritis
JP3356775B2 (ja) 1990-11-30 2002-12-16 セルトリックス ファーマシューティカルズ， インコーポレイテッド ＴＧＦ―βとの共同的組合せによる骨修復のための骨形成タンパク質の使用
US5118667A (en) 1991-05-03 1992-06-02 Celtrix Pharmaceuticals, Inc. Bone growth factors and inhibitors of bone resorption for promoting bone formation
CA2068389A1 (en) 1991-05-13 1992-11-14 Masahiko Sato Method for inhibiting bone resorption
MX9204303A (es) 1991-07-23 1993-11-01 Rhone Poulenc Rorer Int Factor regulador del crecimiento de osteoclasto.
US5366859A (en) * 1991-10-31 1994-11-22 Mitsubishi Petrochemical Co., Ltd. Radioimmunoassay method
US5447851B1 (en) 1992-04-02 1999-07-06 Univ Texas System Board Of Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells
US5427954A (en) * 1992-04-29 1995-06-27 Shriner's Hospitals For Crippled Children Compositions and methods for detection and treatment of human osteoarthritis
US5578569A (en) 1993-03-12 1996-11-26 Tam; Cherk S. Method of increasing bone growth
ES2157991T3 (es) 1993-09-14 2001-09-01 Merck & Co Inc Cadn que codifica una nueva proteina humana, la tirosin-fosfatasa.
AU2753595A (en) * 1994-06-27 1996-01-19 Snow Brand Milk Products Co., Ltd. Novel protein and process for producing the same
EP0727211A1 (en) 1995-02-10 1996-08-21 Smithkline Beecham Corporation Use of src SH2 specific compounds to treat a bone resorption disease
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
WO1996028546A1 (en) 1995-03-15 1996-09-19 Human Genome Sciences, Inc. Human tumor necrosis factor receptor
WO1997000318A1 (en) * 1995-06-07 1997-01-03 Osteosa Inc. Osteoclast growth regulatory factor
WO1997000317A1 (en) 1995-06-07 1997-01-03 Osteosa Inc. Osteoclast growth regulatory factor
US6613544B1 (en) * 1995-12-22 2003-09-02 Amgen Inc. Osteoprotegerin
US6369027B1 (en) * 1995-12-22 2002-04-09 Amgen Inc. Osteoprotegerin
JPH1057071A (ja) 1996-08-19 1998-03-03 Snow Brand Milk Prod Co Ltd 新規ｄｎａ及びそれを用いた蛋白質の製造方法
US5830850A (en) * 1996-08-28 1998-11-03 Mount Sinai School Of Medicine Of The City Of New York Methods for the treatment of bone resorption disorders, including osteoporosis
EP0951546A2 (en) 1996-12-20 1999-10-27 The Board Of Regents, The University Of Texas System Compositions and methods of use for osteoclast inhibitory factors
DE69738841D1 (de) 1996-12-23 2008-08-28 Immunex Corp Ligand für rezeptor aktivator of nf-kappa b, ligand ist mitglied der tnf superfamilie
US5843678A (en) 1997-04-16 1998-12-01 Amgen Inc. Osteoprotegerin binding proteins

Also Published As

Publication number Publication date
NO992472D0 (no) 1999-05-21
KR100547395B1 (ko) 2006-02-01
AU8461798A (en) 1999-04-12
CN1183159C (zh) 2005-01-05
US6693175B2 (en) 2004-02-17
AU739304B2 (en) 2001-10-11
IL129535A0 (en) 2000-02-29
ATE328281T1 (de) 2006-06-15
US20020004207A1 (en) 2002-01-10
DE69834719D1 (de) 2006-07-06
CA2269114A1 (en) 1999-03-24
EP0974671A8 (en) 2002-07-03
RU2203497C2 (ru) 2003-04-27
EP0974671A1 (en) 2000-01-26
IL129535A (en) 2003-07-06
KR20000068916A (ko) 2000-11-25
JP4268684B2 (ja) 2009-05-27
US6998242B2 (en) 2006-02-14
EP0974671A4 (en) 2004-10-22
EP0974671B1 (en) 2006-05-31
ZA986974B (en) 1999-02-04
CN1239515A (zh) 1999-12-22
WO1999015691A1 (fr) 1999-04-01
NO992472L (no) 1999-05-21
NZ335759A (en) 2002-02-01
HUP0002062A2 (hu) 2000-10-28
US20040033533A1 (en) 2004-02-19

Similar Documents

Publication Publication Date Title
ZA989272B (en) Method for making soft tissue
HUP0002062A3 (en) Method for diagnosing bone dysbolism
HUP0000911A3 (en) Refuse-treatment method
GB2345063B (en) Method
GB9721603D0 (en) Method
GB9706282D0 (en) Method
GB2321653B (en) Method for creping tissue
IL118590A0 (en) Methods for minimizing bone loss
GB9700320D0 (en) Method
GB9607287D0 (en) Diagnosis method
GB9707744D0 (en) Method
GB9717652D0 (en) Method
PL341657A1 (en) Deparaffining method
IL118573A0 (en) Methods for minimizing bone loss
EP1042004A4 (en) METHOD FOR TISSUE PERFUSION
HUP9701196A3 (en) Method for producing orthopaedic foot-supports
GB9709811D0 (en) Method
GB9722850D0 (en) Diagnostic method
GB9709865D0 (en) Disinfection method
GB9709437D0 (en) Physiological monitoring method & means
AU136841S (en) An implant
PL103633U1 (en) Back-sight for drilling holles in bones
GB9704313D0 (en) Method
GB9708250D0 (en) Method
GB9711315D0 (en) Method

Legal Events

Date Code Title Description
FC4A Lapse of provisional application due to refusal